COVID-19 has no impact on disease activity, progression and cognitive performance in people with multiple sclerosis: a 2-year study

Conclusions
In PwMS, COVID-19 has no impact on disease activity, course and cognitive performance 18–24 months after infection.

Source: Journal of Neurology, Neurosurgery and Psychiatry - March 13, 2024 Category: Neurosurgery Authors: Montini, F., Nozzolillo, A., Tedone, N., Mistri, D., Rancoita, P. M., Zanetta, C., Mandelli, A., Furlan, R., Moiola, L., Martinelli, V., Rocca, M. A., Filippi, M., On behalf of the Clinical SanRaf MS Study Group Tags: COVID-19 Multiple sclerosis Source Type: research